Sign in to view content

Staring a Clinical Trials Program

David A. Eichenbaum, MD, FASRS

Video
Published 2019

Related

Phase 3 Randomized, Double-Masked Studies of Brolucizumab Versus Aflibercept in nAMD: Expanded Primary and Secondary Outcomes From HAWK/HARRIER
Arshad M. Khanani, MD, MA, FASRS
Annual Meeting Talks
2018
PRISM Phase 2b Clinical Trial Evaluating Intravitreal 4D-150 in Adults With Neovascular Age-Related Macular Degeneration: 52-Week Results
John A. Wells, MD, FACS
Updates from the Field
2025
Episode 17: 5-year Results of DRCR.net Protocol S: PRP laser vs Ranibizumab for PDR with Dr. Jennifer Sun
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018

Category: Practice Management

See more